ത്യാഗവും വിട്ടുവീഴ്ചയും ആവശ്യമാണെന്ന് ഐ‌ഒ‌സി മേധാവി ബാച്ച് സ്പ്രിംഗ് ടോക്കിയോ ഗെയിംസിന് വാതിൽ തുറക്കുന്നു – ടൈംസ് ഓഫ് ഇന്ത്യ
ത്യാഗവും വിട്ടുവീഴ്ചയും ആവശ്യമാണെന്ന് ഐ‌ഒ‌സി മേധാവി ബാച്ച് സ്പ്രിംഗ് ടോക്കിയോ ഗെയിംസിന് വാതിൽ തുറക്കുന്നു – ടൈംസ് ഓഫ് ഇന്ത്യ
March 25, 2020
സെറീന വില്യംസിന്റെയും മേഗൻ മാർക്കിളിന്റെയും സൗഹൃദത്തെക്കുറിച്ച് നിങ്ങൾ അറിയേണ്ടതെല്ലാം – അടിസ്ഥാനപരമായി സ്പോർട്സ്
സെറീന വില്യംസിന്റെയും മേഗൻ മാർക്കിളിന്റെയും സൗഹൃദത്തെക്കുറിച്ച് നിങ്ങൾ അറിയേണ്ടതെല്ലാം – അടിസ്ഥാനപരമായി സ്പോർട്സ്
March 25, 2020
കൊറോണ വൈറസ് പടരുന്നതിനിടയിലാണ് പ്രധാന മലേറിയ മയക്കുമരുന്ന് കയറ്റുമതി ഇന്ത്യ നിരോധിച്ചത് – റോയിട്ടേഴ്‌സ് ഇന്ത്യ

Translating…

NEW DELHI (Reuters) – The Indian government said on Wednesday that it is banning the export of hydroxychloroquine and formulations made from the medication, as experts test the efficacy of the drug in helping treat patients infected with COVID-19.

FILE PHOTO: Researchers at the Microbiology Research Facility work with coronavirus samples as a trial begins to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig/File Photo

There are currently no approved treatments, or preventive vaccines for COVID-19, the highly contagious, sometimes deadly respiratory illness caused by the new coronavirus. Researchers are studying existing treatments and working on experimental ones, but most current patients receive only supportive care such as breathing assistance.

Hydroxychloroquine, a malaria drug, is among the medications that are being tested, as a potential treatment for patients with the disease. Earlier this week, the American Society of Health-System Pharmacists (ASHP), which maintains a list of drug shortages, said hydroxychloroquine was in shortage.

“Chloroquine has demonstrated toxicity in certain patients,” Dinesh Dua, chairman of the Pharmaceuticals Export Promotion Council of India, told Reuters. “You have to tread with caution because there is no comprehensive data to prove it works.”

The group said India faced no shortages of the drug but they warned companies were facing acute shortages of staff to run operations.

Late on Tuesday, India ordered a 21-day lockdown of its 1.3 billion people to try to protect the world’s second most populous country from the fast-spreading coronavirus.

“It is impossible to maintain operations due to lockdown, because employees don’t want to come,” Dua said.

India has already banned export of all ventilators and sanitizers and personal protection equipment such as masks and clothing to contain the outbreak that has so far infected more than 550 people and claimed close to a dozen lives in the country.

The ban comes after India, the world’s largest supplier of generic drugs, this month restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including Paracetamol, a common pain reliever also sold as acetaminophen, as the coronavirus outbreak plays havoc with supply chains. Some of those restrictions have since been relaxed.

For an interactive graphic tracking global spread of coronavirus: open tmsnrt.rs/3aIRuz7 in an external browser.

Reporting by Neha Dasgupta; Editing by Euan Rocha and Edwina Gibbs

Comments are closed.